Evidence map›Paper›PMID 28670664›Full record

ReviewCurrent treatment options in oncology2017

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Ryan C Lynch, Dita Gratzinger, Ranjana H Advani

Erratum issued Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current treatment options in oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03964480 (Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03964480 recruitingnot on this mapstarted 2018, after this paper: background citation

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

Typeobservational_patient_registrySponsorAssociazione Angela Serra per la ricerca sul cancroRan2018 to 2025Enrolled1,000ConditionsPeripheral T-Cell Lymphoma
3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. IgA nephropathy.Nature reviews. Disease primers · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Approach to Peribronchovascular Disease on CT.Seminars in ultrasound, CT, and MR · 2019
    Review
  20. [Clinical observation of five pediatric-type follicular lymphoma in adult].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ryan C LynchDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Dita GratzingerDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Ranjana H AdvaniDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. radvani@stanford.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

opinion statementThe 2016 revision of the WHO classification of lymphoid neoplasms includes new entities along with a clearer definition of provisional and definitive subtypes based on better understanding of the molecular drivers of lymphomas. These changes impact current treatment paradigms and provide a framework for future clinical trials. Additionally, this update recognizes several premalignant or predominantly indolent entities and underscores the importance of avoiding unnecessarily aggressive treatment in the latter subsets.

Indexed as

World Health OrganizationBiomarkers, TumorHumansLymphomaBiomarkers, TumorALK-negative anaplastic large cell lymphoma (ALCL)BCL6 translocationsBurkitt lymphomaChronic lymphocytic leukemia (CLL)Diffuse large B cell lymphoma (DLBCL)Double hit lymphomaFollicular lymphomaHigh grade B cell lymphoma NOSLymphoplasmacytic lymphomaMantle cell lymphomaNon-Hodgkin lymphomaWaldenström macroglobulinemia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.